The Polycystic Ovarian Syndrome PCOS Therapeutics Market continues to expand as gynecologists, endocrinologists, and reproductive medicine specialists increasingly address the multifaceted hormonal, metabolic, and reproductive manifestations of this prevalent endocrine disorder. With PCOS affecting an estimated 8-13% of reproductive-aged women worldwide and representing a leading cause of...